Fifty-one percent risk reduction for hypoglycemia over glyburide in elderly patients with type 2 or non-insulin dependent diabetes, treatment with the short-acting drug repaglinide (Prandin/NovoNorm)..

Obese individuals are at increased risk for developing an acute coronary syndrome (ACS), but because they are treated more aggressively than their lean counterparts, their outcomes are actually better.

An international team of researchers has completed a study that demonstrated a 16-percent reduction in secondary strokes and 35-percent reduction in coronary events in patients who previously experienced a stroke or TIA and were given 80 mg of

Approval of Januvia in Mexico Marks the First DPP-4 Inhibitor, a New Class of Oral Type 2 Diabetes Medicines, to be Approved in the World.

Awareness and better control of postprandial glucose can help to prevent declining cognitive function.

Flavonol-Rich cocoa improves blood vessel function.

Two of the nation’s leaders in improving health care for Americans are collaborating to recognize hospital inpatient diabetes programs that meet national quality standards and raise the quality of care provided to patients with diabetes.

Inhaled human insulin (Exubera) is as effective as glibenclamide as adjunctive therapy in patients with type 2 diabetes.

Night eating is common in diabetic patients and is associated with increased complications.

High blood pressure appears to impair older individuals’ ability to walk, and the reason may be more than just peripheral arterial disease.